1 / 8

Open Angle Glaucoma Market – Global Industry Analysis and Forecast (2024 -2030)

Open Angle Glaucoma Market size was valued at USD 7.88 Bn in 2023 and the total Open Angle Glaucoma revenue is expected to grow by 8 % from 2024 to 2030, reaching USD 13.51 Bn.

priti44
Download Presentation

Open Angle Glaucoma Market – Global Industry Analysis and Forecast (2024 -2030)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Open Angle Glaucoma Market global Analysis Report 2025-230 Published by: Priti, Healthcare

  2. Market Size & Overview: • The open-angle glaucoma market was valued at approximately USD 7.88 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8%, reaching around USD 13.51 billion by 2030. This growth is driven by factors such as an aging global population, increased prevalence of glaucoma, and advancements in diagnostic and therapeutic technologies.

  3. Market Growth & Opportunities The market is experiencing significant growth due to rising awareness about eye health, leading to early diagnosis and treatment. Advancements in medical technology, including minimally invasive surgical procedures and innovative pharmaceuticals, present lucrative opportunities for market expansion. Additionally, increasing investments in research and development are expected to yield novel therapies and improve patient outcomes. Sample Request

  4. Market Segmentation • by Application • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • by End User • Hospital • Homecare • Specialty Clinics • by Product • Open Angle Glaucoma • Angle Closure Glaucoma • by Drug Class • Beta Blockers • Prostaglandins, • Alpha Adrenergic Agonist • Carbonic Anhydrase Inhibitors, • Combination Drugs,

  5. Regional Analysis: • North America: In 2023, North America held a significant market share, primarily due to a well-established healthcare infrastructure, high prevalence of glaucoma, and increasing patient awareness. Advanced diagnostic technologies and favorable reimbursement frameworks further support market growth in this region. • Europe: The European market benefits from robust healthcare systems and a growing elderly population susceptible to glaucoma. Countries like Germany, France, and the UK are key contributors to market growth, driven by increased healthcare expenditure and awareness programs.

  6. Regional Analysis Customized Report Request

  7. Merges and Acquisition • Alcon Inc. Acquires BELKIN Vision Ltd.: In July 2024, Alcon Inc. acquired BELKIN Vision Ltd. for $81 million to enhance its glaucoma treatment portfolio with innovative direct selective laser trabeculoplasty (DSLT) technology. • Alcon's Milestone with Vivity Technology: On March 27, 2024, Alcon highlighted the significance of Vivity's unique, patented wavefront-shaping technology, simplifying presbyopia correction for patients and surgeons. • Orbis'sAI-Powered Screening Program: On January 16, 2024, six specialist fundus cameras were donated to assist Orbis in expanding its AI-powered diabetic retinopathy screening program in Vietnam. Buy This Report

  8. Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com

More Related